List view / Grid view

Imaging

 

news

MSD acquires drug discovery company IOmet

12 January 2016 | By Victoria White

The acquisition includes IOmet's comprehensive preclinical pipeline of IDO (indoleamine-2,3-dioxygenase 1), TDO (tryptophan-2,3-dioxygenase), and dual-acting IDO/TDO inhibitors...